TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ABBV

AbbVie Inc

Healthcare · Drug Manufacturers - General

266.70$ +0.3% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios ABBV
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
Valuation
17.0 17.1 16.6 17.5 21.4 29.2 23.7 22.6 18.9 24.0 22.3 26.2 34.5 16.7 13.4 23.2 21.1 41.4 37.2 30.0 25.4 20.9 23.1 21.5 17.8 24.3 37.3 27.5 40.5 56.5 53.9 56.9 68.3 73.6 88.5 87.4 171.8 95.9 106.0 70.6
4.1 4.0 4.0 4.3 5.2 5.5 5.1 4.7 4.5 4.2 3.7 3.3 3.4 4.0 3.3 4.5 3.8 4.2 3.8 3.7 3.5 4.3 5.1 4.7 4.1 4.9 5.0 4.3 4.8 5.1 5.9 5.5 6.3 5.6 6.5 5.6 6.9 6.6 6.1 6.9
16.0 21.9 20.9 19.3 21.3 30.4 42.5 – – – – – – – – 11.0 10.2 14.6 14.0 15.9 14.1 15.6 17.7 18.5 14.9 16.6 21.3 18.5 21.8 26.4 40.1 44.5 57.6 93.7 253.9 – – – – –
5.3 5.2 5.2 5.5 6.3 6.5 6.1 5.8 5.5 5.2 4.7 4.3 4.3 4.8 4.1 6.7 5.8 5.9 5.3 5.1 4.7 5.5 6.3 5.9 5.1 5.9 6.0 5.2 5.6 5.9 7.0 6.6 7.5 6.7 7.6 6.7 7.9 7.6 7.2 7.9
13.6 13.2 12.9 13.4 15.4 17.6 16.0 16.4 15.1 20.4 18.5 19.8 21.4 13.0 10.7 18.9 15.4 21.8 18.1 15.8 14.2 12.9 14.4 13.7 11.7 14.1 17.1 13.6 16.4 18.7 20.5 20.0 22.7 25.3 29.4 27.7 37.0 26.5 26.6 24.0
14.9 15.5 15.9 17.4 16.9 16.4 15.2 13.5 12.0 10.7 9.1 8.4 8.7 10.3 8.3 11.5 10.1 11.4 10.8 10.2 8.8 10.9 13.1 12.2 10.9 11.8 12.0 9.6 10.7 12.4 14.7 17.1 22.4 17.7 24.1 18.0 19.9 21.7 18.5 22.6
6.7% 6.5% 6.3% 5.7% 5.9% 6.1% 6.6% 7.4% 8.3% 9.4% 11.0% 11.8% 11.5% 9.7% 12.0% 8.7% 9.9% 8.8% 9.3% 9.8% 11.3% 9.1% 7.6% 8.2% 9.2% 8.4% 8.3% 10.4% 9.4% 8.0% 6.8% 5.9% 4.5% 5.7% 4.1% 5.5% 5.0% 4.6% 5.4% 4.4%
Margins
77.2% 77.2% 76.8% 76.8% 76.8% 75.0% 75.2% 74.9% 75.2% 76.4% 77.1% 77.4% 77.3% 77.6% 77.4% 73.6% 68.7% 66.4% 64.8% 65.6% 67.7% 69.0% 69.5% 70.5% 69.6% 70.0% 69.4% 68.9% 65.8% 62.4% 62.3% 62.8% 67.2% 70.0% 70.7% 70.9% 69.7% 70.2% 70.7% 71.5%
36.2% 36.6% 36.3% 36.6% 37.1% 33.9% 33.9% 32.8% 33.0% 19.5% 19.9% 21.8% 20.0% 39.0% 39.9% 30.2% 28.5% 24.8% 23.6% 28.9% 30.1% 31.9% 32.7% 30.3% 30.6% 31.2% 28.5% 31.0% 27.3% 23.5% 23.5% 22.3% 24.9% 16.2% 17.6% 18.8% 15.2% 26.7% 27.6% 29.3%
24.1% 23.2% 24.1% 24.8% 24.4% 18.8% 21.5% 20.8% 23.5% 17.4% 16.4% 12.6% 9.9% 23.7% 24.8% 19.2% 18.2% 10.1% 10.3% 12.4% 13.7% 20.5% 22.0% 22.0% 23.2% 20.4% 13.4% 15.5% 11.8% 9.0% 11.0% 9.7% 9.2% 7.6% 7.3% 6.5% 4.0% 6.9% 5.8% 9.8%
27.5% 25.6% 25.0% 24.9% 31.0% 33.4% 33.6% 35.0% 37.0% 39.0% 40.3% 39.1% 39.3% 38.4% 39.8% 39.0% 37.7% 36.7% 35.4% 36.4% 39.3% 39.1% 38.9% 38.7% 37.9% 41.8% 41.5% 44.3% 44.8% 40.6% 40.2% 32.3% 28.1% 31.7% 26.8% 31.3% 34.5% 30.6% 33.2% 30.6%
Returns
94.0% 128.4% 126.3% 110.1% 99.4% 104.2% 179.6% – – – – – – – – 47.2% 48.3% 35.2% 37.6% 52.9% 55.5% 74.8% 76.5% 86.0% 83.7% 68.5% 57.0% 67.3% 53.7% 46.8% 74.5% 78.3% 84.4% 127.2% 286.9% – – – – –
9.1% 9.0% 9.6% 9.9% 9.7% 7.5% 9.2% 10.5% 11.4% 9.6% 9.4% 7.2% 5.5% 8.8% 9.3% 4.7% 4.9% 3.1% 3.4% 4.5% 5.1% 7.9% 8.7% 8.8% 9.5% 8.5% 5.6% 6.4% 4.8% 3.6% 4.0% 3.8% 3.6% 3.2% 3.1% 2.7% 1.8% 3.2% 2.7% 4.7%
Balance Sheet & Debt
31,092 31,742 32,211 31,149 29,349 28,065 28,280 34,199 33,193 33,021 32,344 32,186 27,868 26,920 25,904 81,415 79,169 77,782 75,775 73,592 68,539 67,116 67,376 64,411 57,774 54,236 55,382 52,256 47,459 46,571 55,934 57,504 63,822 61,620 64,714 64,014 63,114 62,267 63,467 64,253
3.1 3.1 3.0 2.8 2.6 2.7 2.5 3.1 2.8 4.0 3.9 4.5 4.3 2.2 2.0 6.3 5.2 6.3 5.1 4.3 3.7 2.8 2.7 2.6 2.3 2.2 2.8 2.4 2.5 2.7 3.0 3.2 3.5 4.1 4.4 4.5 4.9 3.5 3.8 3.0
9.7% 7.0% 7.6% 9.0% 9.7% 7.2% 5.1% -5.5% -4.4% -14.2% -13.8% -15.0% -13.8% -9.2% -8.1% 9.9% 10.2% 8.7% 9.1% 8.5% 9.1% 10.5% 11.4% 10.3% 11.3% 12.5% 9.9% 9.5% 8.9% 7.7% 5.4% 4.8% 4.2% 2.5% 1.1% -0.1% -1.9% -2.4% -4.8% -4.4%
5.8 7.9 7.4 6.2 5.7 7.3 10.5 – – – – – – – – 5.9 5.7 6.6 6.2 6.5 5.9 5.0 4.5 5.0 4.3 3.7 4.7 4.7 5.0 5.7 9.2 10.4 11.7 20.0 47.8 – – – – –
Per Share
3.71 3.67 3.94 4.13 4.15 3.31 4.00 4.10 4.99 3.84 3.61 2.77 2.19 5.31 5.68 4.22 4.16 2.59 2.91 3.75 4.24 6.49 7.02 7.12 7.55 6.66 4.27 4.90 3.68 2.74 3.38 3.01 2.89 2.41 2.37 2.12 1.35 2.38 2.05 3.57
15.39 15.80 16.36 16.69 17.01 17.61 18.55 19.69 21.25 22.11 22.01 21.98 22.16 22.40 22.95 22.00 22.91 25.72 28.28 30.25 31.05 31.61 31.90 32.29 32.56 32.65 31.95 31.63 31.13 30.65 30.68 31.06 31.34 31.77 32.37 32.92 33.66 34.48 35.41 36.36
3.94 2.86 3.12 3.76 4.17 3.18 2.23 -2.15 -1.93 -5.70 -5.28 -5.77 -5.55 -5.50 -5.00 8.94 8.62 7.35 7.74 7.09 7.64 8.68 9.18 8.27 9.02 9.72 7.49 7.28 6.85 5.87 4.54 3.85 3.43 1.90 0.83 -0.08 -1.47 -1.82 -3.73 -3.35
4.24 4.04 4.09 4.16 5.28 5.89 6.23 6.89 7.87 8.63 8.88 8.61 8.72 8.60 9.13 8.57 8.64 9.43 10.02 11.02 12.20 12.37 12.40 12.51 12.34 13.64 13.24 14.00 13.96 12.45 12.35 10.04 8.82 10.06 8.68 10.29 11.61 10.54 11.76 11.11

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?